Genetic Engineering News: Microalgal Vessicles Deliver Therapeutics to Protected Tissues On December 7, 2022 / OPUS Clients in the News Read more →
GeekWire: Seattle Startup HDT Bio Lands $1.8M US Army Grant to Develop Nasal Spray Against Viruses On August 11, 2022 / OPUS Clients in the News Read more →
Pharmaceutical Technology: HDT Bio receives Emergency Use Approval for Covid-19 Vaccine in India On June 30, 2022 / OPUS Clients in the News Read more →
New York Times: Here’s Why Developing Countries Can Make MRNA Covid Vaccines On October 22, 2021 / OPUS Clients in the News Read more →
Ophthalmology Times: Optogenetic Gene Therapy Restores Vision in 11 RP Patients On June 3, 2021 / OPUS Clients in the News Read more →
BioWorld: Kineta Crafting Seaworthy RIG in Cancer after Merck Sets Sail with German Buy. On March 28, 2018 / OPUS Clients in the News Read more →
Ovarian Cancer News: First Patient Enrolled in NanoPac Trial Evaluating New Anti-Cancer Treatment Delivery On October 17, 2017 / OPUS Clients in the News Read more →
Practical Dermatology: Update from DFB Soria on Enrollment in Phase 2 Clinical Trial of Nanoparticle Paclitaxel Ointment for AK On October 3, 2017 / OPUS Clients in the News Read more →
Cancer Treatment: DFB Pharmaceuticals forms new company that could revolutionize cancer treatment On October 3, 2017 / OPUS Clients in the News Read more →
BioWorld: ‘Bare’-ish on naked effort, Nanology unveils particle approach across cancers. On October 3, 2017 / OPUS Clients in the News Read more →
